Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu
- 1 December 2006
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 59 (12) , 1327-1330
Abstract
Adenoid cystic/basal cell carcinoma (ACBCC) is a rare neoplasm in the prostate. Definitive treatment is warranted, as among 19 patients previously reported by us, 5 had extraprostatic extension and 4 were metastatic. The HER-2/neu ( c-erbB-2 ) gene has been reportedly overexpressed in adenoid cystic carcinomas in other organs, but its status in prostatic ACBCC was uncertain. Immunohistochemical staining and in situ hybridisation were carried out in 13 patients with ACBCC (11 from transurethral resection, 2 prostatectomy). One patient had metastasis to the lung. Citrate buffer and steam heat were used for antigen retrieval. Ten acinar adenocarcinomas of varying grades were also immunostained as controls. Protein and mRNA expression were 2+ to 3+ (of 3+) in all patients with ACBCC, compared to a breast cancer control with strong reactivity, whereas protein expression was noted in only one acinar carcinoma and mRNA expression was absent in all acinar carcinomas. Benign acini expressed HER-2/neu only in the basal layer. The finding of strong, consistent HER-2/neu expression in ACBCC suggests that treatment with Herceptin (trastuzumab) may be effective in patients with this rare tumour.Keywords
This publication has 12 references indexed in Scilit:
- Correlation of Her-2/neu Gene Amplification with Other Prognostic and Predictive Factors in Female Breast CarcinomaThe Breast Journal, 2005
- Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expressionJournal of Clinical Pathology, 2005
- Basal Cell Proliferations of the Prostate Other Than Usual Basal Cell HyperplasiaAmerican Journal of Surgical Pathology, 2004
- Adenoid Cystic/Basal Cell Carcinoma of the ProstateAmerican Journal of Surgical Pathology, 2003
- Dedifferentiated Adenoid Cystic Carcinoma: A Clinicopathologic Study of 6 CasesLaboratory Investigation, 2003
- Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.2003
- Evaluation of HER‐2/neu expression in prostatic adenocarcinomaCancer, 2002
- Adenoid cystic carcinoma of the trachea and bronchus – a clinicopathologic study with DNA flow cytometric analysis and oncogene expressionEuropean Journal of Cardio-Thoracic Surgery, 2002
- HER‐2/neu is overexpressed infrequently in patients with prostate carcinomaCancer, 2002
- [What is the real importance of evaluating the expression of c-erbB-2 (HER-2/neu) in carcinoma of the breast and prostate? (A short review)].2002